The Global Cone-Rod Dystrophy Market is expected to grow at a CAGR of approximately 5.3% during the forecast period 2017-2023. Cone Rod Dystrophy Market Research Report– By Diagnosis (ERG, Clinical History, Fundus Examination, Molecular Diagnosis), By Treatment (Tinted Lenses, Medication, Magnifying Devices), By End User (Hospitals, Ophthalmic Centers) – Global Forecast Till 2023
The cone rod dystrophy, also known as cone-rod degeneration, progressive cone-rod dystrophy, and retinal cone dystrophy, is an inherited disease that causes an overtime deterioration of the retina. People with cone-rod dystrophy typically experience decreased clarity of vision followed by a loss of peripheral vision and color blindness. The most common form of cone-rod dystrophy is retinitis pigmentosa.
Increasing age is also one of the major factors for causing ophthalmic complications. A number of changes in the eye muscles and nerves occur as the age increase. According to WHO, 82% of people living with blindness are aged 50 and above. Some ophthalmologists believe that treatment with high doses of Vitamin A can slow the progression. Increased risk of genetic inheritance and increasing geriatric population are the key factors driving the growth of the global cone rod dystrophy market during the forecast period.
To Get Free Sample Report visit https://www.marketresearchfuture.com/sample_request/5262
Key Players for Global Cone-Rod Dystrophy Market
Some of key the players in the global cone rod dystrophy market are
- GlaxoSmithKline Plc (U.S.),
- Johnson & Johnson (U.S.),
- Sanofi (Switzerland),
- Pfizer Inc. (U.S.),
- Novartis AG (Switzerland),
- Abbott Laboratories (U.S.),
- Sunovion Pharmaceuticals (U.S.),
- Cephalon (U.S.),
- DSM (India),
- Amway (U.S.),
- Vitamin Shoppe (U.S.),
- Intas Pharmaceutials Limited (India),
- Sun Pharmaceuticals Ltd. (India)
- Emcure Pharmaceuticals Limited (India),
- Nutrilite (U.S.),
- NutraScience Labs (U.S.), and others.
Segments for Global Cone-Rod Dystrophy Market
The cone rod dystrophy is segmented on the basis of diagnosis, treatment, and end-users.
On the basis of the diagnosis, the market is segmented into Electroretinogram (ERG), clinical history, fundus examination, molecular diagnosis, and others.
On the basis of the treatment, the market is segmented into tinted lenses/ dark sunglass, medications, magnifying devices, and surgery. The medication is classified into vitamin A supplement and anticonvulsant.
On the basis of the end-user, the market is segmented into hospitals, ophthalmic centers, research organizations, and academic institutes.
Regional Analysis for Global Cone-Rod Dystrophy Market
Global cone rod dystrophy consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East.
The Americas hold the second largest share of the global cone rod dystrophy market owing to the growing incidence of eye disorders. According to National Eye Institute (NEI), blindness or low vision will affect more than 5.5 million Americans age 40 and over by 2020.
The European market dominated the global cone rod dystrophy market owing to the high prevalence rate of this disease in the Germany and Italy and other Western European countries. The European market is anticipated to compete with the American market during the forecasted period 2017-2023. Target 5000 is a Fighting Blindness research project which aims to provide genetic testing for an estimated 5,000 people in Ireland who are diagnosed with any inherited retinal condition. The purpose of this project is to provide a precise diagnosis and more detailed information about the nature and inheritance pattern of the condition.
The Asia Pacific is expected to be the fastest growing region in the global cone rod dystrophy market.
To Browse Complete Report Visit https://www.marketresearchfuture.com/reports/cone-rod-dystrophy-market-5262
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
TOC Continued…
To Get an Exclusive Discount on Report Visit https://www.marketresearchfuture.com/check-discount/5262
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312